Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.

(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)